Hypertension and diabetes mellitus
To evaluate hypertension in patients with Diabetes Mellitus (DM) and its correlation with age, duration of DM, Body Mass Index (BMI) and HbA1C). A retrospective study was made on 1211 patients with DM (male 554 and female 657), hospitalized at Clinic of Endocrinology between January 2001 and Decembe...
Gespeichert in:
| Veröffentlicht in: | Prilozi - Makedonska akademija na naukite i umetnostite. Oddelenie za biološki i medicinski nauki 2004, Vol.25 (1-2), p.17-26 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | mac |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 26 |
|---|---|
| container_issue | 1-2 |
| container_start_page | 17 |
| container_title | Prilozi - Makedonska akademija na naukite i umetnostite. Oddelenie za biološki i medicinski nauki |
| container_volume | 25 |
| creator | Petrovski, G Dimitrovski, C Sadikario, S Bogoev, M Milenković, T |
| description | To evaluate hypertension in patients with Diabetes Mellitus (DM) and its correlation with age, duration of DM, Body Mass Index (BMI) and HbA1C).
A retrospective study was made on 1211 patients with DM (male 554 and female 657), hospitalized at Clinic of Endocrinology between January 2001 and December 2002. Patients were divided in two groups: Control group (CG)-subdivided into 3 groups patients with DM type 1 (CG-1), DM type 2 on oral anti-hyper-glycemic agents (CG-2)and DM type 2 on insulin therapy (CG-3) and Examined Group (EG), the same groups for diabetes, including hypertension.
We found hypertension in 12.6% patients with DM type 1, 30.5% in DM type 2 on oral anti-hyper-glycemic agents and 33.4% in DM type 2 on insulin therapy.
Hypertension is mostly presented in DM type 2 patients (33,4%), instead of 12.6% in DM type 1. There is statistical significance (p |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67254806</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67254806</sourcerecordid><originalsourceid>FETCH-LOGICAL-p543-1c3563a3716fadf46d372308c0ceca59f767ed04afbde41e868fba901f226e723</originalsourceid><addsrcrecordid>eNo1jztrwzAUhTW0NCHNXyimQzaD5KtXxhDSphDokt1cS1eg4lcse8i_r6DpWc7ycTjfE1tzUKKESskV26b0w3OU5QDiha2EMqAUwJq9n-8jTTP1KQ59gb0vfMSGZkpFR20b5yW9sueAbaLtozfs-nG6Hs_l5fvz63i4lKOSUAoHSgOCETqgD1J7MBVw67gjh2ofjDbkucTQeJKCrLahwT0Xoao0ZXTDdn-z4zTcFkpz3cXk8gfsaVhSrU12sVxn8O0BLk1Hvh6n2OF0r_-l4BdiMUcf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67254806</pqid></control><display><type>article</type><title>Hypertension and diabetes mellitus</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Petrovski, G ; Dimitrovski, C ; Sadikario, S ; Bogoev, M ; Milenković, T</creator><creatorcontrib>Petrovski, G ; Dimitrovski, C ; Sadikario, S ; Bogoev, M ; Milenković, T</creatorcontrib><description>To evaluate hypertension in patients with Diabetes Mellitus (DM) and its correlation with age, duration of DM, Body Mass Index (BMI) and HbA1C).
A retrospective study was made on 1211 patients with DM (male 554 and female 657), hospitalized at Clinic of Endocrinology between January 2001 and December 2002. Patients were divided in two groups: Control group (CG)-subdivided into 3 groups patients with DM type 1 (CG-1), DM type 2 on oral anti-hyper-glycemic agents (CG-2)and DM type 2 on insulin therapy (CG-3) and Examined Group (EG), the same groups for diabetes, including hypertension.
We found hypertension in 12.6% patients with DM type 1, 30.5% in DM type 2 on oral anti-hyper-glycemic agents and 33.4% in DM type 2 on insulin therapy.
Hypertension is mostly presented in DM type 2 patients (33,4%), instead of 12.6% in DM type 1. There is statistical significance (p<0.05) between duration of DM in patients with and without hypertension.</description><identifier>ISSN: 0351-3254</identifier><identifier>PMID: 15735533</identifier><language>mac</language><publisher>Germany</publisher><subject>Adult ; Diabetes Mellitus, Type 1 - complications ; Diabetes Mellitus, Type 2 - complications ; Female ; Humans ; Hypertension - complications ; Male ; Middle Aged</subject><ispartof>Prilozi - Makedonska akademija na naukite i umetnostite. Oddelenie za biološki i medicinski nauki, 2004, Vol.25 (1-2), p.17-26</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4023</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15735533$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Petrovski, G</creatorcontrib><creatorcontrib>Dimitrovski, C</creatorcontrib><creatorcontrib>Sadikario, S</creatorcontrib><creatorcontrib>Bogoev, M</creatorcontrib><creatorcontrib>Milenković, T</creatorcontrib><title>Hypertension and diabetes mellitus</title><title>Prilozi - Makedonska akademija na naukite i umetnostite. Oddelenie za biološki i medicinski nauki</title><addtitle>Prilozi</addtitle><description>To evaluate hypertension in patients with Diabetes Mellitus (DM) and its correlation with age, duration of DM, Body Mass Index (BMI) and HbA1C).
A retrospective study was made on 1211 patients with DM (male 554 and female 657), hospitalized at Clinic of Endocrinology between January 2001 and December 2002. Patients were divided in two groups: Control group (CG)-subdivided into 3 groups patients with DM type 1 (CG-1), DM type 2 on oral anti-hyper-glycemic agents (CG-2)and DM type 2 on insulin therapy (CG-3) and Examined Group (EG), the same groups for diabetes, including hypertension.
We found hypertension in 12.6% patients with DM type 1, 30.5% in DM type 2 on oral anti-hyper-glycemic agents and 33.4% in DM type 2 on insulin therapy.
Hypertension is mostly presented in DM type 2 patients (33,4%), instead of 12.6% in DM type 1. There is statistical significance (p<0.05) between duration of DM in patients with and without hypertension.</description><subject>Adult</subject><subject>Diabetes Mellitus, Type 1 - complications</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - complications</subject><subject>Male</subject><subject>Middle Aged</subject><issn>0351-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1jztrwzAUhTW0NCHNXyimQzaD5KtXxhDSphDokt1cS1eg4lcse8i_r6DpWc7ycTjfE1tzUKKESskV26b0w3OU5QDiha2EMqAUwJq9n-8jTTP1KQ59gb0vfMSGZkpFR20b5yW9sueAbaLtozfs-nG6Hs_l5fvz63i4lKOSUAoHSgOCETqgD1J7MBVw67gjh2ofjDbkucTQeJKCrLahwT0Xoao0ZXTDdn-z4zTcFkpz3cXk8gfsaVhSrU12sVxn8O0BLk1Hvh6n2OF0r_-l4BdiMUcf</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>Petrovski, G</creator><creator>Dimitrovski, C</creator><creator>Sadikario, S</creator><creator>Bogoev, M</creator><creator>Milenković, T</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>2004</creationdate><title>Hypertension and diabetes mellitus</title><author>Petrovski, G ; Dimitrovski, C ; Sadikario, S ; Bogoev, M ; Milenković, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p543-1c3563a3716fadf46d372308c0ceca59f767ed04afbde41e868fba901f226e723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>mac</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Diabetes Mellitus, Type 1 - complications</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - complications</topic><topic>Male</topic><topic>Middle Aged</topic><toplevel>online_resources</toplevel><creatorcontrib>Petrovski, G</creatorcontrib><creatorcontrib>Dimitrovski, C</creatorcontrib><creatorcontrib>Sadikario, S</creatorcontrib><creatorcontrib>Bogoev, M</creatorcontrib><creatorcontrib>Milenković, T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Prilozi - Makedonska akademija na naukite i umetnostite. Oddelenie za biološki i medicinski nauki</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Petrovski, G</au><au>Dimitrovski, C</au><au>Sadikario, S</au><au>Bogoev, M</au><au>Milenković, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypertension and diabetes mellitus</atitle><jtitle>Prilozi - Makedonska akademija na naukite i umetnostite. Oddelenie za biološki i medicinski nauki</jtitle><addtitle>Prilozi</addtitle><date>2004</date><risdate>2004</risdate><volume>25</volume><issue>1-2</issue><spage>17</spage><epage>26</epage><pages>17-26</pages><issn>0351-3254</issn><abstract>To evaluate hypertension in patients with Diabetes Mellitus (DM) and its correlation with age, duration of DM, Body Mass Index (BMI) and HbA1C).
A retrospective study was made on 1211 patients with DM (male 554 and female 657), hospitalized at Clinic of Endocrinology between January 2001 and December 2002. Patients were divided in two groups: Control group (CG)-subdivided into 3 groups patients with DM type 1 (CG-1), DM type 2 on oral anti-hyper-glycemic agents (CG-2)and DM type 2 on insulin therapy (CG-3) and Examined Group (EG), the same groups for diabetes, including hypertension.
We found hypertension in 12.6% patients with DM type 1, 30.5% in DM type 2 on oral anti-hyper-glycemic agents and 33.4% in DM type 2 on insulin therapy.
Hypertension is mostly presented in DM type 2 patients (33,4%), instead of 12.6% in DM type 1. There is statistical significance (p<0.05) between duration of DM in patients with and without hypertension.</abstract><cop>Germany</cop><pmid>15735533</pmid><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0351-3254 |
| ispartof | Prilozi - Makedonska akademija na naukite i umetnostite. Oddelenie za biološki i medicinski nauki, 2004, Vol.25 (1-2), p.17-26 |
| issn | 0351-3254 |
| language | mac |
| recordid | cdi_proquest_miscellaneous_67254806 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Adult Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 2 - complications Female Humans Hypertension - complications Male Middle Aged |
| title | Hypertension and diabetes mellitus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A57%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypertension%20and%20diabetes%20mellitus&rft.jtitle=Prilozi%20-%20Makedonska%20akademija%20na%20naukite%20i%20umetnostite.%20Oddelenie%20za%20biolo%C5%A1ki%20i%20medicinski%20nauki&rft.au=Petrovski,%20G&rft.date=2004&rft.volume=25&rft.issue=1-2&rft.spage=17&rft.epage=26&rft.pages=17-26&rft.issn=0351-3254&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E67254806%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67254806&rft_id=info:pmid/15735533&rfr_iscdi=true |